Aytu BioPharma Inc.
1.63
0.01 (0.62%)
At close: Jan 15, 2025, 11:13 AM

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07
Cash & Equivalents 20.01M 22.98M 19.36M 49.65M 48.08M 11.04M 7.01M 802.33K 8.05M 7.35M 2.64M 1.86K 109.00 3.99K 1.54K 13.61K 37.64K 23.36K
Short-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a 1.04M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments n/a -1.38M n/a -10.91M -1.80M n/a n/a n/a n/a -41.43K n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets 2.23M 792.00K 766.00K 465.00K 32.98K 2.20K 4.72K 2.89K 216.36K 339.82K 457.25K -770.06K n/a n/a n/a n/a n/a n/a
Receivables 23.62M 28.94M 21.71M 28.18M 5.63M 1.74M 578.78K 528.04K 162.43K 157.06K n/a n/a n/a n/a n/a n/a n/a n/a
Inventory 12.63M 11.99M 10.85M 16.34M 10.00M 1.44M 1.34M 1.31M 524.71K 39.44K 10.45K n/a n/a n/a n/a n/a n/a n/a
Other Current Assets 5.63M 8.91M 8.01M 11.07M 11.71M 1.21M 540.01K 385.97K 337.54K 534.30K 171.00 n/a 77.00 234.00 172.00 257.00 164.00 n/a
Total Current Assets 61.89M 72.83M 59.93M 105.23M 74.97M 15.43M 9.47M 3.03M 10.12M 8.08M 3.30M 1.86K 186.00 4.23K 1.72K 13.87K 37.81K 23.36K
Property-Plant & Equipment 1.52M 3.87M 6.30M 8.70M 892.61K 203.73K 219.00K 647.25K 231.43K 30.00K 57.00K 7.52K 12.46K 18.61K 25.37K 27.98K 36.27K 36.31K
Goodwill & Intangibles 52.45M 58.97M 70.63M 151.27M 76.94M 19.08M 11.37M 11.32M 13.77M 9.77M 8.20M 770.35K n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 56.20M 63.63M 77.69M 160.43M 77.87M 19.29M 11.59M 11.97M 14.22M 10.14M 8.71M 7.81K 12.46K 18.61K 25.37K 27.98K 36.27K 36.31K
Total Assets 118.09M 136.46M 137.62M 265.67M 152.84M 34.72M 21.06M 15.00M 24.34M 18.23M 12.02M 9.67K 12.65K 22.84K 27.09K 41.85K 74.07K 59.67K
Account Payables 10.44M 13.48M 10.99M 19.25M 11.64M 2.13M 2.12M 2.22M 2.32M 1.20M 310.00 6.84K 5.84K 330.00 477.00 n/a n/a 1.74K
Deferred Revenue n/a 46.80M n/a 57.23M 339.34K n/a n/a n/a n/a 85.71K 85.71K 264.17K n/a n/a n/a n/a n/a n/a
Short-Term Debt 4.25M 85.00K 3.91M 24.70M 1.28M n/a n/a n/a n/a n/a 30.98K 99.51K 68.05K 52.30K 77.60K 54.62K 48.12K 34.40K
Other Current Liabilities 47.54M 55.45M 49.55M 65.48M 15.67M 3.24M 1.28M 1.39M 7.78M 197.95K 19.21K 14.17K 8.47K 5.80K 4.62K 820.00 n/a 4.73K
Total Current Liabilities 62.23M 69.02M 64.44M 109.44M 28.31M 5.37M 3.39M 3.61M 10.10M 1.48M 6.09M 120.53K 82.36K 58.43K 82.70K 55.44K 48.12K 40.87K
Long-Term Debt 10.88M 14.71M 14.28M 5.43M 725.00K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities 17.27M 13.38M 12.81M 13.23M 28.79M 22.26M 4.24M 7.39M 4.15M 664.00K n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities 28.15M 28.09M 27.09M 18.66M 29.51M 22.26M 4.24M 7.39M 4.15M 1.13M 554.41K n/a 73.90K 52.63K 78.08K 54.62K 48.12K 36.14K
Total Liabilities 90.38M 97.11M 91.53M 128.10M 57.82M 27.63M 7.64M 11.00M 14.26M 2.61M 6.65M 120.53K 82.36K 58.43K 82.70K 55.44K 48.12K 40.87K
Total Debt 15.13M 16.36M 18.19M 28.35M 2.01M n/a n/a n/a n/a n/a 4.60M 99.51K 68.05K 52.30K 77.60K 54.62K 48.12K 34.40K
Common Stock 1K 1K 4.00K 3.00K 12.58K 1.75K 179.00 82.00 374.00 1.43K 790.00 414.03K n/a n/a 1K n/a 205.25K n/a
Retained Earnings -319.97M -304.13M -288.47M -178.30M -120.01M -106.39M -79.26M -69.07M -46.56M -18.38M -10.66M -568.70K -500 -500 -500 -254.14K -195.75K -138.57K
Comprehensive Income n/a n/a -0.00 0.00 n/a n/a 0.00 -246.00K -112.00K -5.00M -33.00K 10.47M -510.89K -451.21K -314.41K -1.26K 449.00 417.00
Shareholders Equity 27.72M 39.36M 46.09M 137.57M 95.02M 7.09M 13.42M 4.00M 10.09M 15.62M 5.37M -110.86K -69.72K -35.59K -55.61K -13.58K 25.96K 18.81K
Total Investments -762.00K -1.38M n/a -10.91M -1.80M n/a n/a n/a 1.04M -41.43K n/a n/a n/a n/a n/a n/a n/a n/a